Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001401914-21-000041
Filing Date
2021-03-30
Accepted
2021-03-30 16:44:26
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dare-20201231.htm   iXBRL 10-K 2144819
2 EX-21.1 dare-20201231xex211.htm EX-21.1 4121
3 EX-23.1 dare-20201231xex231.htm EX-23.1 3716
4 EX-31.1 dare-20201231xex311.htm EX-31.1 7983
5 EX-31.2 dare-20201231xex312.htm EX-31.2 7990
6 EX-32.1 dare-20201231xex321.htm EX-32.1 4033
7 EX-32.2 dare-20201231xex322.htm EX-32.2 3888
13 dare-20201231_g1.jpg GRAPHIC 130914
14 dare-20201231_g2.jpg GRAPHIC 139396
  Complete submission text file 0001401914-21-000041.txt   8369532

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20201231.xsd EX-101.SCH 57795
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20201231_cal.xml EX-101.CAL 72437
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20201231_def.xml EX-101.DEF 276802
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20201231_lab.xml EX-101.LAB 660313
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20201231_pre.xml EX-101.PRE 424683
15 EXTRACTED XBRL INSTANCE DOCUMENT dare-20201231_htm.xml XML 926706
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36395 | Film No.: 21786532
SIC: 2834 Pharmaceutical Preparations